Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab
In this video, I discuss the dosage recommendations for BPC-157
When these systems are supported, cells may be better able to: Manage everyday stressors Support healthy repair processes Maintain efficient clean energy production Support balanced inflammatory and detox pathways Maintain resilience during times of increased metabolic demand Support healthy aging at the cellular level Why you need both: A balanced approach to cellular resilience Supporting one and not the other is a lot like maintaining engine oil in your car (NAD+) but ignoring the air filter (glutathione), or vice versa
the invention proposes the use of reduced glutathione encapsulated in a liposome (liposomal reduced glutathione) for the oral administration of a therapeutically effective amount to improve symptoms in disease states related to diminished function of the methylation pathway, and also proposes combining methylcobalamin, and/or Insulin Growth Factor 1 (IGF-1) with liposomal reduced glutathione to accomplish such improvement
Where one of the things that he's enlightened me on, because I'm not a geneticist, I don't know anything about that world he's like, dude, if you do a gene sequencing test on a guy like Gordon Ryan, maybe there's a gene that's causing him to have these stomach issues
